{"nct_id":"NCT02512068","title":"A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease","status":"COMPLETED","status_verified_date":"2023-12","start_date":"2015-08-07","start_date_type":"ACTUAL","primary_completion_date":"2018-04-24","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}